EGF and Alzheimer disease: BMB6, implicated in dysregulated neurogenesis in AD, was found to mediate increased AD-specific interactions between pericyte subtypes and excitatory neurons, whereas EGF (epidermal growth factor) signaling pathway mediated decreased AD-specific interactions between astrocytes and capillary endothelial cells.